Skip to main content
Premium Trial:

Request an Annual Quote

Biogemma to Partner with Roche NimbleGen

NEW YORK (GenomeWeb News) — Genetics-focused agriculture company Biogemma said today that it will use Roche NimbleGen's Sequence Capture technology in a research collaboration.
The co-development partnership is aimed at developing new technologies for Biogemma’s crop plant-breeding programs. The focus will be on polyploidy plant genomes such as wheat and canola.
Using the Sequence Capture complexity reduction technology will help Biogemma target unique genetic variations associated with genes that will be useful to crop breeders, said Roche NimbleGen. The partnership also will employ recent optimizations of the Sequence Capture technology for 454’s GS FLX Titanium series.
“Wheat and canola are very valuable crops for our seed business shareholders and, due to their genome structure, remain very challenging to develop efficient molecular markers on a larger scale,” Biogemma CEO Pascual Perez said in a statement.
Perez added that the agreement will assist in “development of numerous genetic markers linked to important traits,” and it will help Biogemma customers “speed their breeding programs and reduce their time to market, both of which will have a significant impact on agriculture.”
Financial terms of the agreement were not released.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.